April 30 (Reuters) - Stryker Corp ( SYK ) lifted its

full-year profit forecast on Tuesday, owing to resilient demand

for the company's medical devices and implants.

The joint-implant maker now sees its annual profit per share

to be between $11.85 and $12.05, raised from the previous range

of between $11.70 and $12. The analysts' average estimate for

2024 is pegged at $11.85 per share.

Demand for medical implants has received a boost as more

people, especially older adults, opt for surgeries deferred

during the pandemic

Stryker now expects organic net sales growth for 2024 to be

in the range of 8.5% to 9.5%, compared with its earlier

projected range of 7.5% to 9%.

The company reported a 9.7% rise in quarterly revenue to

$5.24 billion, compared with estimates of $5.10 billion,

according to LSEG data.

On an adjusted basis, it reported a profit of $2.50 per

share for the quarter ended March 31, above analysts' estimate

of $2.35 per share.